Clinical trial
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
NCT01175226
Study timeline
Study start (unknown)2010-08-01Date precision: month
Registry last updated2018-05-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rhinovirusunresolved
Interventions
Sponsors & collaborators
Biota Scientific Management Pty Ltdlead sponsor
Mapped research locations
PittsburghPennsylvania, United States2CincinnatiOhio, United States2Oklahoma CityOklahoma, United States2OmahaNebraska, United States2New YorkNew York, United States1BostonMassachusetts, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1San AntonioTexas, United States1RichmondVirginia, United States1BethesdaMaryland, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01175226 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.